April 2024
1. SMITH LC, Mateos AC, Due AS, Bergstrom J, et al
   Immersive virtual reality in the treatment of auditory hallucinations: A PRISMA scoping review.
   Psychiatry Res. 2024;334:115834.
   

   >> Share

   
   March 2024
2. SPINAZZOLA E, Quattrone D, Quattrone A, Murray RM, et al
   The increased incidence of psychosis during the COVID-19 pandemic in South London: The role of heavy cannabis use.
   Psychiatry Res. 2024;336:115869.
   

   >> Share

   
   
3. HAMZEHPOUR L, Bohn T, Dutsch V, Jaspers L, et al
   From brain to body: exploring the connection between altered reward processing and physical fitness in schizophrenia.
   Psychiatry Res. 2024;335:115877.
   

   >> Share

   
   
4. GALLEGO JA, McNamara RK, Blanco EA, Castaneda S, et al
   Evidence for cytokine dysregulation in schizophrenia spectrum disorders: A comparison of cerebrospinal fluid and blood samples.
   Psychiatry Res. 2024;335:115871.
   

   >> Share

   
   
5. SEFIK E, Guest RM, Aberizk K, Espana R, et al
   Psychosis spectrum symptoms among individuals with schizophrenia-associated copy number variants and evidence of cerebellar correlates of symptom severity.
   Psychiatry Res. 2024;335:115867.
   

   >> Share

   
   
6. SETHI S, Wakeham D, Ketter T, Hooshmand F, et al
   Ketogenic Diet Intervention on Metabolic and Psychiatric Health in Bipolar and Schizophrenia: A Pilot Trial.
   Psychiatry Res. 2024;335:115866.
   

   >> Share

   
   
7. YANG H, Zhu D, Liu Y, Xu Z, et al
   Employing graph attention networks to decode psycho-metabolic interactions in Schizophrenia.
   Psychiatry Res. 2024;335:115841.
   

   >> Share

   
   
8. KISHI T, Citrome L, Sakuma K, Iwata N, et al
   A comparison of recurrence rates after discontinuation of second-generation antipsychotic long-acting injectable versus corresponding oral antipsychotic in the maintenance treatment of bipolar disorder: A systematic review.
   Psychiatry Res. 2024;333:115761.
   

   >> Share

   
   February 2024
9. GORORA ME, Dalkner N, Moore RC, Depp CA, et al
   A meta-cognitive Wisconsin Card Sorting Test in people with schizophrenia and bipolar disorder: Self-assessment of sorting performance.
   Psychiatry Res. 2024;334:115831.
   

   >> Share

   
   
10. QIN K, Yu Y, Cai H, Li J, et al
    Effectiveness of mindfulness-based intervention in schizophrenia: A meta-analysis of randomized controlled trials.
    Psychiatry Res. 2024;334:115808.
    

    >> Share

    
    
11. KIKUCHI Y, Komatsu H, Otsuka Y, Ito F, et al
    Effect of concomitant use of valproic acid during clozapine initiation on clozapine-induced inflammation among Japanese patients with schizophrenia.
    Psychiatry Res. 2024;334:115810.
    

    >> Share

    
    
12. GOODING DC, Mohrbacher DA, Umucu E, Van Hulle CA, et al
    Ethnoracialized group differences in attitudes and knowledge about schizophrenia and willingness to engage in biomarker research: The UBIGR Study.
    Psychiatry Res. 2024;334:115776.
    

    >> Share

    
    
13. HYATT AS, Mulvaney-Day N, Chow CM, Cook BL, et al
    Association between electronic nicotine product use and subsequent first episode psychosis.
    Psychiatry Res. 2024;334:115785.
    

    >> Share

    
    
14. KWAK PP, Ibarra C, Hernandez A, Carrasco J, et al
    Differences in metabolic biomarkers in people with schizophrenia who are of Mexican descent compared to non-Hispanic whites.
    Psychiatry Res. 2024;334:115788.
    

    >> Share

    
    
15. QUIRINO AHA, da Rocha MEC, Andrade AGM, E Souza FGM, et al
    The demonstrated association: Cannabis use and onset of psychosis in the study by Medeiros et al., refuting the reverse notion.
    Psychiatry Res. 2024;334:115771.
    

    >> Share

    
    January 2024
16. HE R, Palominos C, Zhang H, Alonso-Sanchez MF, et al
    Navigating the semantic space: Unraveling the structure of meaning in psychosis using different computational language models.
    Psychiatry Res. 2024;333:115752.
    

    >> Share

    
    
17. KOS C, Bais L, Klaasen N, Opmeer E, et al
    Effects of right prefrontal theta-burst transcranial magnetic stimulation or transcranial direct current stimulation on apathy in patients with schizophrenia: A multicenter RCT.
    Psychiatry Res. 2024;333:115743.
    

    >> Share

    
    
18. YI S, Wang Q, Wang W, Hong C, et al
    Efficacy of repetitive transcranial magnetic stimulation (rTMS) on negative symptoms and cognitive functioning in schizophrenia: An umbrella review of systematic reviews and meta-analyses.
    Psychiatry Res. 2024;333:115728.
    

    >> Share

    
    
19. TOUMAIAN M, Covanis P, Mantas A, Karantinos T, et al
    Multisensory integration deficits in Schizophrenia and Autism evidenced in behaviour but not event related potentials.
    Psychiatry Res. 2024;332:115727.
    

    >> Share

    
    
20. PROHENS L, Rodriguez N, Segura AG, Martinez-Pinteno A, et al
    Gene expression imputation provides clinical and biological insights into treatment-resistant schizophrenia polygenic risk.
    Psychiatry Res. 2024;332:115722.
    

    >> Share

    
    
21. JEROME L, Matanov A, Bird V, Priebe S, et al
    Comparison of subjective quality of life domains in schizophrenia, mood, and anxiety disorders; an individual patient data meta-analysis.
    Psychiatry Res. 2024;332:115707.
    

    >> Share

    
    
22. CHU RST, Chong RCH, Chang DHH, Shan Leung AL, et al
    The risk of stroke and post-stroke mortality in people with schizophrenia: A systematic review and meta-analysis study.
    Psychiatry Res. 2024;332:115713.
    

    >> Share

    
    
23. SETIEN-SUERO E, Ayesa-Arriola R, Pena J, Ojeda N, et al
    Premorbid adjustment as predictor of long-term functionality: Findings from a 10-year follow-up study in the PAFIP-cohort.
    Psychiatry Res. 2024;331:115674.
    

    >> Share

    
    
24. MASTELLARI T, Saint-Dizier C, Fovet T, Geoffroy PA, et al
    Exploring seasonality in catatonia diagnosis: Evidence from a large-scale population study.
    Psychiatry Res. 2024;331:115652.
    

    >> Share

    
    December 2023
25. WANG Y, Zhang X
    The role of immune inflammation in electroconvulsive therapy for schizophrenia: Treatment mechanism, and relationship with clinical efficacy: Immune-inflammation in ECT for schizophrenia.
    Psychiatry Res. 2023;332:115708.
    

    >> Share

    
    
26. VGONTZAS AN, Paschalidou A, Simos PG, Anastasaki M, et al
    Impact of long-acting injectable antipsychotics vs. oral medication on relapses of patients with psychosis and bipolar disorder.
    Psychiatry Res. 2023;332:115676.
    

    >> Share

    
    
27. TORREY EF
    Did the human genome project affect research on Schizophrenia?
    Psychiatry Res. 2023;333:115691.
    

    >> Share

    
    
28. KIM WS, Shen J, Tsogt U, Odkhuu S, et al
    Altered thalamic volumes and functional connectivity in the recovered patients with psychosis.
    Psychiatry Res. 2023;331:115688.
    

    >> Share

    
    
29. ZHOU D, Xie H, Chen L, Zhu Z, et al
    The cognitive improvement in patients with schizophrenia following low-intensity repetitive transcranial magnetic stimulation could last for 6 months: A randomized controlled trial.
    Psychiatry Res. 2023;332:115672.
    

    >> Share

    
    
30. CHEN Y, Zhang L, Sun Y, Wang W, et al
    Prevalence of constipation in patients with schizophrenia: A systematic review and meta-analysis.
    Psychiatry Res. 2023;331:115659.
    

    >> Share

    
    
31. DE MEDEIROS MW, Andrade JC, Haddad NM, Mendonca M, et al
    Cannabis use influences disorganized symptoms severity but not transition in a cohort of non-help-seeking individuals at-risk for psychosis from Sao Paulo, Brazil.
    Psychiatry Res. 2023;331:115665.
    

    >> Share

    
    
32. DEAN B, Duce J, Li QX, Masters CL, et al
    Lower levels of soluble beta-amyloid precursor protein, but not beta-amyloid, in the frontal cortex in schizophrenia.
    Psychiatry Res. 2023;331:115656.
    

    >> Share

    
    
33. FENG XZ, Li Z, Li ZY, Wang K, et al
    Effectiveness and safety of second-generation antipsychotics for psychiatric disorders apart from schizophrenia: A systematic review and meta-analysis.
    Psychiatry Res. 2023;332:115637.
    

    >> Share

    
    
34. VINOGRADOV S
    Harnessing neuroplasticity.
    Psychiatry Res. 2023;330:115607.
    

    >> Share

    
    
35. STAFFORD E, Jakob S, Gur RE, Corcoran CM, et al
    Securing direct stakeholder feedback to inform clinical research in serious mental illness: Results of a patient and family perspectives survey.
    Psychiatry Res. 2023;330:115574.
    

    >> Share

    
    November 2023
36. GROENING JM, Denton E, Parvaiz R, Brunet DL, et al
    A systematic evidence map of the association between cannabis use and psychosis-related outcomes across the psychosis continuum: An umbrella review of systematic reviews and meta-analyses.
    Psychiatry Res. 2023;331:115626.
    

    >> Share

    
    
37. LAMANNA-RAMA N, Romero-Miguel D, Casquero-Veiga M, MacDowell KS, et al
    THC improves behavioural schizophrenia-like deficits that CBD fails to overcome: a comprehensive multilevel approach using the Poly I:C maternal immune activation.
    Psychiatry Res. 2023;331:115643.
    

    >> Share

    
    
38. WEI Z, Wang Y, Hu L, Wang Y, et al
    Incidence, prevalence, and mortality of schizophrenia from 2016 to 2020 in Shandong, China.
    Psychiatry Res. 2023;331:115612.
    

    >> Share

    
    
39. LEE J, Xue X, Au E, McIntyre WB, et al
    Central insulin dysregulation in antipsychotic-naive first-episode psychosis: In silico exploration of gene expression signatures.
    Psychiatry Res. 2023;331:115636.
    

    >> Share

    
    
40. CUESTA MJ, Gil-Berrozpe GJ, Sanchez-Torres AM, Moreno-Izco L, et al
    20-Year trajectories of six psychopathological dimensions in patients with first-episode psychosis: Could they be predicted?
    Psychiatry Res. 2023;331:115614.
    

    >> Share

    
    
41. HU Q, Jiao X, Zhou J, Tang Y, et al
    Low-frequency repetitive transcranial magnetic stimulation over the right orbitofrontal cortex for patients with first-episode schizophrenia: A randomized, double-blind, sham-controlled trial.
    Psychiatry Res. 2023;330:115600.
    

    >> Share

    
    
42. BOGE K, Hallford DJ, Pillny M
    Mindfulness, psychological flexibility and their relationship with psychopathology in persons with schizophrenia-spectrum-disorders and healthy controls - A multicenter cross-sectional study.
    Psychiatry Res. 2023;330:115591.
    

    >> Share

    
    
43. DAZZAN P
    Disentangling psychosis: The challenges of informing precision medicine for what is not a single disorder.
    Psychiatry Res. 2023;330:115596.
    

    >> Share

    
    
44. BERNARDIN F, Gauld C, Martin VP, Laprevote V, et al
    The 68 symptoms of the clinical high risk for psychosis: Low similarity among fourteen screening questionnaires.
    Psychiatry Res. 2023;330:115592.
    

    >> Share

    
    
45. CORNBLATT BA, McFarlane WR, Carrion RE
    Authors' reply to comments on: Recreational cannabis use over time in individuals at clinical high risk for psychosis: Lack of associations with symptom, neurocognitive, functioning, and treatment patterns.
    Psychiatry Res. 2023;330:115594.
    

    >> Share

    
    
46. KIRSHENBAUM AP, Sofis MJ, Slade M
    Response to recreational cannabis use over time in individuals at clinical high risk for psychosis: lack of associations with symptom, neurocognitive, functioning, and treatment patterns by Carrion et al., 2023.
    Psychiatry Res. 2023;330:115589.
    

    >> Share

    
    
47. PARK S
    Schizophrenia in the mind, the brain and the body.
    Psychiatry Res. 2023;329:115547.
    

    >> Share

    
    October 2023
48. BIRONG CHEN, Tan XW, Tor PC
    The impact of the number of previous illness episodes on early response to electroconvulsive therapy (ECT) in psychosis, mania, depression, psychotic depression, and catatonia: A naturalistic transdiagnostic analysis.
    Psychiatry Res. 2023;330:115580.
    

    >> Share

    
    
49. KIM HK, Goncalves VF, Husain MI, Muller DJ, et al
    Cross-disorder GWAS meta-analysis of endocannabinoid DNA variations in major depressive disorder, bipolar disorder, attention deficit hyperactivity disorder, autism spectrum disorder, and schizophrenia.
    Psychiatry Res. 2023;330:115563.
    

    >> Share

    
    
50. LIN CH, Huang CJ, Lin TC, Chan HY, et al
    Schizophrenia patients discharged on antipsychotic polypharmacy from a public psychiatric hospital in Taiwan, 2006-2021.
    Psychiatry Res. 2023;330:115575.
    

    >> Share

    
    
51. WANG P, Jiang Y, Hoptman MJ, Li Y, et al
    Structural-functional connectivity deficits of callosal-white matter-cortical circuits in schizophrenia.
    Psychiatry Res. 2023;330:115559.
    

    >> Share

    
    
52. VAN DER TUIN S, Booij SH, Muller MK, van den Berg D, et al
    The added value of daily diary data in 1- and 3-year prediction of psychopathology and psychotic experiences in individuals at risk for psychosis.
    Psychiatry Res. 2023;329:115546.
    

    >> Share

    
    
53. HASSAN L, Eisner E, Berry K, Emsley R, et al
    User engagement in a randomised controlled trial for a digital health intervention for early psychosis (Actissist 2.0 trial).
    Psychiatry Res. 2023;329:115536.
    

    >> Share

    
    
54. SCHLIEF M, Rich N, Rains LS, Baldwin H, et al
    Ethnic differences in receipt of psychological interventions in Early Intervention in Psychosis services in England - a cross-sectional study.
    Psychiatry Res. 2023;330:115529.
    

    >> Share

    
    
55. ZHANG T, Xu L, Wei Y, Tang X, et al
    Duration of untreated prodromal psychosis among individuals with clinical high risk for psychosis.
    Psychiatry Res. 2023;329:115522.
    

    >> Share

    
    September 2023
56. SAMPEDRO A, Pena J, Sanchez P, Ibarretxe-Bilbao N, et al
    Moderators of functional improvement after integrative cognitive remediation in schizophrenia: Toward a personalized treatment approach.
    Psychiatry Res. 2023;329:115495.
    

    >> Share

    
    
57. HUI CLM, Wong CCL, Chan EWT, Suen YN, et al
    COVID-19 exposure and psychosis: A comparison of clinical, functional, and cognitive profiles in remitted patients with psychosis.
    Psychiatry Res. 2023;328:115487.
    

    >> Share

    
    
58. CAMPRODON-BOADAS P, De la Serna E, Plana MT, Flamarique I, et al
    Delusional beliefs in adolescents with anorexia nervosa, obsessive-compulsive disorder, or first-episode psychosis: A comparative study.
    Psychiatry Res. 2023;328:115490.
    

    >> Share

    
    
59. BALDINI V, Stefano RD, Rindi LV, Ahmed AO, et al
    Association between adverse childhood experiences and suicidal behavior in schizophrenia spectrum disorders: A systematic review and meta-analysis.
    Psychiatry Res. 2023;329:115488.
    

    >> Share

    
    
60. GEBREEGZIABHERE Y, Habatmu K, Cella M, Alem A, et al
    Introducing an interview-based cognitive assessment tool for people with Schizophrenia in Ethiopia.
    Psychiatry Res. 2023;328:115474.
    

    >> Share

    
    
61. SANCHEZ-TORRES AM, Garcia de Jalon E, Gil-Berrozpe GJ, Peralta V, et al
    Cognitive intraindividual variability, cognitive impairment and psychosocial functioning in first-episode psychosis patients.
    Psychiatry Res. 2023;328:115473.
    

    >> Share

    
    
62. FORDHAM E, Gao CX, Filia K, O'Donoghue B, et al
    Social disadvantage in early psychosis and its effect on clinical presentation and service access, engagement and use.
    Psychiatry Res. 2023;328:115478.
    

    >> Share

    
    
63. MAURUS I, Roell L, Lembeck M, Papazova I, et al
    Exercise as an add-on treatment in individuals with schizophrenia: Results from a large multicenter randomized controlled trial.
    Psychiatry Res. 2023;328:115480.
    

    >> Share

    
    
64. INCHAUSTI L, Gorostiza I, Gonzalez Torres MA, Oraa R, et al
    The transition to Schizophrenia spectrum disorder from a first psychotic episode that did or did not appear to be induced by substance use.
    Psychiatry Res. 2023;328:115475.
    

    >> Share

    
    
65. FANG X, Gao C, Wu W, Hu X, et al
    The role of the gut microbiome in weight-gain in schizophrenia patients treated with atypical antipsychotics: Evidence based on altered composition and function in a cross-sectional study.
    Psychiatry Res. 2023;328:115463.
    

    >> Share

    
    
66. ZHANG J, Yang Y, Liu T, Shi Z, et al
    Functional connectivity in people at clinical and familial high risk for schizophrenia.
    Psychiatry Res. 2023;328:115464.
    

    >> Share

    
    
67. SMITH ECC, Au E, Pereira S, Sharma E, et al
    Clinical improvement in schizophrenia during antipsychotic treatment in relation to changes in glucose parameters: A systematic review.
    Psychiatry Res. 2023;328:115472.
    

    >> Share

    
    
68. LUCKHOFF HK, Asmal L, Smit R, Phahladira L, et al
    Sex, gender, and outcome in first-episode psychosis: The role of premorbid functioning.
    Psychiatry Res. 2023;328:115460.
    

    >> Share

    
    
69. SEGAL SP, Rimes L, Badran L
    Crime and victimization outcomes following civil rights limits to the use of compulsory treatment.
    Psychiatry Res. 2023;327:115377.
    

    >> Share

    
    
70. JOSHI YB, Gonzalez CE, Molina JL, MacDonald LR, et al
    Mismatch negativity predicts initial auditory-based targeted cognitive training performance in a heterogeneous population across psychiatric disorders.
    Psychiatry Res. 2023;327:115215.
    

    >> Share

    
    
71. XIE Y, Guan M, Wang Z, Ma Z, et al
    Alterations in brain connectivity patterns in schizophrenia patients with auditory verbal hallucinations during low frequency repetitive transcranial magnetic stimulation.
    Psychiatry Res. 2023;328:115457.
    

    >> Share

    
    August 2023
72. KUUSKMAE C, Philips MA, Kilk K, Haring L, et al
    Kynurenine pathway dynamics in patients with schizophrenia spectrum disorders across the disease trajectory.
    Psychiatry Res. 2023;328:115423.
    

    >> Share

    
    
73. CARRION RE, Auther AM, McLaughlin D, Adelsheim S, et al
    Recreational cannabis use over time in individuals at clinical high risk for psychosis: Lack of associations with symptom, neurocognitive, functioning, and treatment patterns.
    Psychiatry Res. 2023;328:115420.
    

    >> Share

    
    
74. ZHANG Y, Lu Z, Sun Y, Zhang X, et al
    Predictive role of pulvinar in social functional outcome of schizophrenia.
    Psychiatry Res. 2023;327:115419.
    

    >> Share

    
    
75. JOHANSSON M, Hjarthag F, Helldin L
    Exploring cross-sectional and longitudinal symptomatic remission and subjective quality of life in schizophrenia.
    Psychiatry Res. 2023;328:115421.
    

    >> Share

    
    
76. FEKIH-ROMDHANE F, Abassi B, Ghrissi F, Loch AA, et al
    Suicide risk among individuals at Ultra-High Risk (UHR) of psychosis in a developing North African country: A 12-month naturalistic prospective cohort study from the TRIP project.
    Psychiatry Res. 2023;327:115409.
    

    >> Share

    
    
77. ALEKSANDROWICZ A, Kowalski J, Stefaniak I, Elert K, et al
    Cognitive correlates of auditory hallucinations in schizophrenia spectrum disorders.
    Psychiatry Res. 2023;327:115372.
    

    >> Share

    
    
78. LIU X, Xu L, Gong J, Ye Q, et al
    The effect of high-dose accelerated continuous theta burst stimulation (cTBS) treatment on auditory verbal hallucinations (AVH): A pilot study.
    Psychiatry Res. 2023;326:115337.
    

    >> Share

    
    
79. LOCH AA, Pinto MTC, Andrade JC, de Jesus LP, et al
    Plasma levels of neurotrophin 4/5, NGF and pro-BDNF influence transition to mental disorders in a sample of individuals at ultra-high risk for psychosis.
    Psychiatry Res. 2023;327:115402.
    

    >> Share

    
    July 2023
80. HEMAGER N, Gregersen M, Christiani CJ, Hjorthoj C, et al
    Development of social functioning in preadolescent children at familial high-risk of schizophrenia or bipolar disorder - a 4-year follow-up study from age 7 to 11.
    Psychiatry Res. 2023;327:115397.
    

    >> Share

    
    
81. DAI J, Zhang MZ, He QQ, Chen R, et al
    The emerging role of exosomes in Schizophrenia.
    Psychiatry Res. 2023;327:115394.
    

    >> Share

    
    
82. KONDRATYEV NV, Alfimova MV, Kaleda VG, Lezheiko TV, et al
    Assessing the impact of the de novo SLC6A1 mutation in schizophrenia through a comprehensive case study.
    Psychiatry Res. 2023;327:115399.
    

    >> Share

    
    
83. ZHANG T, Wei Y, Cui H, Tang X, et al
    Associations between age and neurocognition in individuals at clinical high risk and first-episode psychosis.
    Psychiatry Res. 2023;327:115385.
    

    >> Share

    
    
84. WANG C, Tishler TA, Nuechterlein KH, Ellingson BM, et al
    Cortical thickness, gray-white matter contrast, and intracortical myelin in first-episode schizophrenia patients treated with long-acting paliperidone palmitate versus oral antipsychotics.
    Psychiatry Res. 2023;326:115364.
    

    >> Share

    
    June 2023
85. CHEN X, Tan W, Cheng Y, Huang D, et al
    Polygenic risk for schizophrenia and the language network: Putative compensatory reorganization in unaffected siblings.
    Psychiatry Res. 2023;326:115319.
    

    >> Share

    
    
86. PANARIELLO F, Zamparini M, Picchioni M, Nielssen OB, et al
    Exposure to violence in childhood and risk of violence in adult schizophrenia: Results from a multinational study.
    Psychiatry Res. 2023;326:115299.
    

    >> Share

    
    
87. CHU RYK, Wei Y, Osborn DP, Ng VWS, et al
    Breast cancer risks following antipsychotic use in women with bipolar disorder versus schizophrenia: A territory-wide nested case-control study spanning two decades.
    Psychiatry Res. 2023;326:115287.
    

    >> Share

    
    
88. OKADA H, Sawamura D, Kunita K, Ogasawara H, et al
    Prefrontal activation during simulated driving in people with schizophrenia: A functional near-infrared spectroscopy study.
    Psychiatry Res. 2023;326:115285.
    

    >> Share

    
    May 2023
89. VEDDUM L, Greve AN, Gregersen M, Andreassen AK, et al
    A study of the genetic architecture of social responsiveness in families with parental schizophrenia or bipolar disorder and population-based controls.
    Psychiatry Res. 2023;326:115280.
    

    >> Share

    
    
90. TATAR O, Abdel-Baki A, Dyachenko A, Bakouni H, et al
    Evaluating preferences for online psychological interventions to decrease cannabis use in young adults with psychosis: An observational study.
    Psychiatry Res. 2023;326:115276.
    

    >> Share

    
    
91. LEE JJ, Piras E, Tamburini S, Bu K, et al
    Gut and oral microbiome modulate molecular and clinical markers of schizophrenia-related symptoms: A transdiagnostic, multilevel pilot study.
    Psychiatry Res. 2023;326:115279.
    

    >> Share

    
    
92. SHADOWEN N, Meehan Z, Webb C, Fowles T, et al
    Early intervention in youth psychosis: Novel approaches to understanding change.
    Psychiatry Res. 2023;326:115269.
    

    >> Share

    
    
93. COHN J
    Elaboration of some points in "The association of gender dysphoria with psychosis".
    Psychiatry Res. 2023;325:115264.
    

    >> Share

    
    
94. LI Q, Gong Y, Cui Y, Cheng C, et al
    Efficacy of transcutaneous electrical acupoint stimulation for patients with first-episode schizophrenia: An 8-week, preliminary, randomized controlled trial.
    Psychiatry Res. 2023;325:115255.
    

    >> Share

    
    
95. WOJTALIK JA, Brown WJ, Mesholam-Gately RI, Kotwani A, et al
    Predictors of treatment discontinuation during an 18-month multi-site randomized trial of Cognitive Enhancement Therapy for early course schizophrenia.
    Psychiatry Res. 2023;326:115254.
    

    >> Share

    
    
96. CIAMPELLI S, Voppel AE, de Boer JN, Koops S, et al
    Combining automatic speech recognition with semantic natural language processing in schizophrenia.
    Psychiatry Res. 2023;325:115252.
    

    >> Share

    
    
97. ZHANG H, Parola A, Zhou Y, Wang H, et al
    Linguistic markers of psychosis in Mandarin Chinese: Relations to theory of mind.
    Psychiatry Res. 2023;325:115253.
    

    >> Share

    
    
98. REICH N, Delavari F, Schneider M, Thillainathan N, et al
    Multivariate patterns of disrupted sleep longitudinally predict affective vulnerability to psychosis in 22q11.2 Deletion Syndrome.
    Psychiatry Res. 2023;325:115230.
    

    >> Share

    
    
99. SANCHEZ RUIZ JA, Coombes BJ, Pendegraft RS, Ozerdem A, et al
    Pharmacotherapy exposure as a marker of disease complexity in bipolar disorder: Associations with clinical & genetic risk factors.
    Psychiatry Res. 2023;323:115174.
    

    >> Share

    
    
100. BUCK B, Wingerson M, Chander A, Tauscher JS, et al
     A preliminary study examining terminology used by individuals with lived experience describing beliefs about being targeted or harmed by others.
     Psychiatry Res. 2023;323:115129.
     

     >> Share

     
     April 2023
101. FUNG VSC, Chan JCY, Wong SCY, Wong CSM, et al
     Investigation of momentary negative symptoms in patients with early psychosis in daily life: An experience sampling study.
     Psychiatry Res. 2023;325:115234.
     

     >> Share

     
     
102. TOLL A, Pechuan E, Berge D, Legido T, et al
     Factors associated with suicide attempts in first-episode psychosis during the first two years after onset.
     Psychiatry Res. 2023;325:115232.
     

     >> Share

     
     
103. BENUTO LT, Done M, Zepeda M, Fitzgerald J, et al
     A systematic review of persons of color participation in first episode psychosis coordinated specialty care randomized controlled trials in North America.
     Psychiatry Res. 2023;325:115221.
     

     >> Share

     
     
104. TROTTI RL, Parker DA, Sabatinelli D, Keshavan MS, et al
     Emotional scene processing in biotypes of psychosis.
     Psychiatry Res. 2023;324:115227.
     

     >> Share

     
     
105. LU Z, Zhang Y, Sun Y, Liao Y, et al
     The positive association between antipsychotic-induced weight gain and therapeutic response: New biotypes of schizophrenia.
     Psychiatry Res. 2023;324:115226.
     

     >> Share

     
     
106. O'CONNELL KS, Koch E, Lenk HC, Akkouh IA, et al
     Polygenic overlap with body-mass index improves prediction of treatment-resistant schizophrenia.
     Psychiatry Res. 2023;325:115217.
     

     >> Share

     
     
107. DE THURAH L, Kiekens G, Sips R, Teixeira A, et al
     Using Experience Sampling Methods to support clinical management of psychosis: The perspective of people with lived experience.
     Psychiatry Res. 2023;324:115207.
     

     >> Share

     
     
108. ELVEVAG B
     Reflections on measuring disordered thoughts as expressed via language.
     Psychiatry Res. 2023;322:115098.
     

     >> Share

     
     
109. TONYALI A, Karacetin G, Ocakoglu BK, Atay A, et al
     Development and validation of Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS) for Internet Gaming Disorder (IGD) and factor analytic assessment.
     Psychiatry Res. 2023;324:115187.
     

     >> Share

     
     March 2023
110. FUSAR-POLI L, Prachason T, Erzin G, Pries LK, et al
     Examining the association between exposome score for schizophrenia and cognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study.
     Psychiatry Res. 2023;323:115184.
     

     >> Share

     
     
111. GARRIDO-TORRES N, Alameda L, Suarez MLS, Rocha Gonzalez I, et al
     Corrigendum "Higher rates of first episode psychosis in immigrants admitted in inpatient unit at southwest Spain" [Psychiatry Res. 308 (2022) 114352].
     Psychiatry Res. 2023 Mar 27:115146. doi: 10.1016/j.psychres.2023.115146.
     

     >> Share

     
     
112. XU H, Zhou Y, Wang J, Liang Z, et al
     Effect of HD-tDCS on white matter integrity and associated cognitive function in chronic schizophrenia: A double-blind, sham-controlled randomized trial.
     Psychiatry Res. 2023;324:115183.
     

     >> Share

     
     
113. SUEN YN, Pang SWT, Cheung C, Wong TY, et al
     Impact of early negative symptom patterns on the long-term outcomes of patients with first-episode schizophrenia-spectrum disorders: A 12-year follow up study.
     Psychiatry Res. 2023;323:115180.
     

     >> Share

     
     
114. POLETTI M, Pelizza L, Loas G, Azzali S, et al
     Anhedonia and suicidal ideation in young people with early psychosis: Further findings from the 2-year follow-up of the ReARMS program.
     Psychiatry Res. 2023;323:115177.
     

     >> Share

     
     
115. TUCCI AA, Schroeder A, Noel C, Shvetz C, et al
     Social cognition in youth with a first-degree relative with schizophrenia: A systematic scoping review.
     Psychiatry Res. 2023;323:115173.
     

     >> Share

     
     
116. PETKARI E
     Can we really define the effect of psychological interventions on Quality of Life for patients with schizophrenia based on the most recent meta-analysis in the field?
     Psychiatry Res. 2023 Mar 20:115149. doi: 10.1016/j.psychres.2023.115149.
     

     >> Share

     
     
117. GOUSE BM, Boliver EE, Oblath R, Camacho L, et al
     Cannabis use among patients presenting to the emergency department for psychosis: Associations with restraint use, medication administration, psychiatric hospitalization, and repeat visits.
     Psychiatry Res. 2023;323:115151.
     

     >> Share

     
     
118. AIREY ND, Taylor CDJ, Vikram A, Berry K, et al
     Trauma measures for use with psychosis populations: A systematic review of psychometric properties using COSMIN.
     Psychiatry Res. 2023;323:115163.
     

     >> Share

     
     
119. MEDALIA A, Saperstein A, Javitt DC, Qian M, et al
     Feasibility and clinical utility of using the tone matching test for assessment of early auditory processing in schizophrenia.
     Psychiatry Res. 2023;323:115152.
     

     >> Share

     
     
120. PALMA-ALVAREZ RF, Daigre C, Ros-Cucurull E, Perea-Ortueta M, et al
     Clinical features and factors related to lifetime suicidal ideation and suicide attempts in patients who have had substance-induced psychosis across their lifetime.
     Psychiatry Res. 2023;323:115147.
     

     >> Share

     
     
121. LIN BD, Vermeulen JM, Bolhuis K, Chang X, et al
     Associations between genetic liabilities to smoking behavior and schizophrenia symptoms in patients with a psychotic disorder, their siblings and healthy controls.
     Psychiatry Res. 2023;323:115143.
     

     >> Share

     
     
122. FIVEL L, Mondino M, Brunelin J, Haesebaert F, et al
     Basic auditory processing and its relationship with symptoms in patients with schizophrenia: A systematic review.
     Psychiatry Res. 2023;323:115144.
     

     >> Share

     
     
123. XIE M, Cai J, Liu Y, Wei W, et al
     Association between childhood trauma and white matter deficits in first-episode schizophrenia.
     Psychiatry Res. 2023;323:115111.
     

     >> Share

     
     
124. VEDDUM L, Gregersen M, Andreassen AK, Knudsen CB, et al
     Social responsiveness in families with parental schizophrenia or bipolar disorder-The Danish High Risk and Resilience Study.
     Psychiatry Res. 2023;323:115140.
     

     >> Share

     
     
125. TAVARES VDO, Rossell SL, Schuch FB, Herring M, et al
     Effects of exercise on cognitive functioning in adults with serious mental illness: A meta analytic review.
     Psychiatry Res. 2023;321:115081.
     

     >> Share

     
     
126. NIZNIKIEWICZ MA
     From communication dysfunction to treatment options in serious mental illness.
     Psychiatry Res. 2023;321:115062.
     

     >> Share

     
     
127. DO KQ
     Bridging the gaps towards precision psychiatry: Mechanistic biomarkers for early detection and intervention.
     Psychiatry Res. 2023;321:115064.
     

     >> Share

     
     
128. DUBOURG L, Kojovic N, Eliez S, Schaer M, et al
     Visual processing of complex social scenes in 22q11.2 deletion syndrome: Relevance for negative symptoms.
     Psychiatry Res. 2023;321:115074.
     

     >> Share

     
     
129. CAI J, Li L, Shao T, Sun M, et al
     Relapse in patients with schizophrenia and amisulpride-induced hyperprolactinemia or olanzapine-induced metabolic disturbance after switching to other antipsychotics.
     Psychiatry Res. 2023;322:115138.
     

     >> Share

     
     February 2023
130. PONCE-CORREA F, Caqueo-Urizar A, Berrios R, Escobar-Soler C, et al
     Defining recovery in schizophrenia: A review of outcome studies.
     Psychiatry Res. 2023;322:115134.
     

     >> Share

     
     
131. WANG Y, Wang J, Su W, Hu H, et al
     Symptom-circuit mappings of the schizophrenia connectome.
     Psychiatry Res. 2023;323:115122.
     

     >> Share

     
     
132. MA X, Yang WFZ, Zheng W, Li Z, et al
     Neuronal dysfunction in individuals at early stage of schizophrenia, A resting-state fMRI study.
     Psychiatry Res. 2023;322:115123.
     

     >> Share

     
     
133. PERALTA V, de Jalon EG, Moreno-Izco L, Peralta D, et al
     A clinical staging model of psychotic disorders based on a long-term follow-up of first-admission psychosis: A validation study.
     Psychiatry Res. 2023;322:115109.
     

     >> Share

     
     
134. ROMEO B, Willaime L, Rari E, Benyamina A, et al
     Efficacy of 5-HT2A antagonists on negative symptoms in patients with schizophrenia: A meta-analysis.
     Psychiatry Res. 2023;321:115104.
     

     >> Share

     
     
135. STEFFENSEN NL, Hemager N, Bundgaard AF, Gantriis DL, et al
     Affective lability in parents with schizophrenia or bipolar disorder and their co-parents - The Danish High Risk and Resilience Study VIA 7.
     Psychiatry Res. 2023;321:115092.
     

     >> Share

     
     
136. DUDLEY R, Denton S, Mathewson J, Pervez S, et al
     Prevalence of multisensory hallucinations in people at risk of transition to psychosis.
     Psychiatry Res. 2023;322:115091.
     

     >> Share

     
     
137. LUO G, Li Y, Yao C, Li M, et al
     Duration of untreated illness and clinical correlates in first-episode and drug-naive patients with major depressive disorder.
     Psychiatry Res. 2023;320:115056.
     

     >> Share

     
     
138. AAS M, Ueland T, Lagerberg TV, Melle I, et al
     Retrospectively assessed childhood trauma experiences are associated with illness severity in mental disorders adjusted for symptom state.
     Psychiatry Res. 2023;320:115045.
     

     >> Share

     
     
139. OLAYA B, Moneta MV, Plana-Ripoll O, Haro JM, et al
     Association between mental disorders and mortality: A register-based cohort study from the region of Catalonia.
     Psychiatry Res. 2023;320:115037.
     

     >> Share

     
     January 2023
140. KIM AM, Sohn JH
     The impact of the Mental Health Act revision for deinstitutionalization in Korea on the crime rate of people with schizophrenia.
     Psychiatry Res. 2023;321:115089.
     

     >> Share

     
     
141. TAN EJ, Neill E, Kleiner JL, Rossell SL, et al
     Depressive symptoms are specifically related to speech pauses in schizophrenia spectrum disorders.
     Psychiatry Res. 2023;321:115079.
     

     >> Share

     
     
142. BORKENT J, Ioannou M, Folkertsma TS, Wardenaar KJ, et al
     Serum free thiols in recently diagnosed patients with schizophrenia spectrum disorder: A potentially useful biomarker of oxidative stress.
     Psychiatry Res. 2023;321:115075.
     

     >> Share

     
     
143. ESPOSITO CM, Biagianti B, D'Agostino A, Dell'Osso B, et al
     First episode psychosis during the Covid-19 pandemic in Milan, Italy: Diagnostic outcomes at 1-year follow-up.
     Psychiatry Res. 2023;321:115068.
     

     >> Share

     
     
144. SONG M, Liu Y, Zhou J, Shi H, et al
     Potential plasma biomarker panels identification for the diagnosis of first-episode schizophrenia and monitoring antipsychotic monotherapy with the use of metabolomics analyses.
     Psychiatry Res. 2023;321:115070.
     

     >> Share

     
     
145. RICCI V, Ceci F, Di Carlo F, Di Muzio I, et al
     First episode psychosis with and without the use of cannabis and synthetic cannabinoids: Psychopathology, global functioning and suicidal ideation and antipsychotic effectiveness.
     Psychiatry Res. 2023;320:115053.
     

     >> Share

     
     
146. MINOR KS, Lundin NB, Myers EJ, Fernandez-Villardon A, et al
     Automated measures of speech content and speech organization in schizophrenia: Test-retest reliability and generalizability across demographic variables.
     Psychiatry Res. 2023;320:115048.
     

     >> Share

     
     
147. 
     Letter to Editor regarding "Higher rates of first episode psychosis in immigrants admitted in inpatient unit at southwest Spain".
     Psychiatry Res. 2023;322:115016.
     

     >> Share

     
     
148. KULKARNI J
     Estrogen - A key neurosteroid in the understanding and treatment of mental illness in women.
     Psychiatry Res. 2023;319:114991.
     

     >> Share

     
     
149. MOTA NB
     How can computational tools help to understand language patterns in mental suffering considering social diversity.
     Psychiatry Res. 2023;319:114995.
     

     >> Share

     
     December 2022
150. DELISI LE
     Brain plasticity, language anomalies, genetic risk and the patient with schizophrenia: Trajectory of change over a lifetime. A commentary.
     Psychiatry Res. 2022;320:115034.
     

     >> Share

     
     
151. GALDERISI S
     Negative symptoms of schizophrenia: Trying to answer unanswered research questions.
     Psychiatry Res. 2022;320:115043.
     

     >> Share

     
     
152. LI L, Rami FZ, Lee BM, Kim WS, et al
     Predictors of full recovery in patients with early stage schizophrenia spectrum disorders.
     Psychiatry Res. 2022;320:115035.
     

     >> Share

     
     
153. JIN Y, Tong J, Huang Y, Shi D, et al
     Effectiveness of accelerated intermittent theta burst stimulation for social cognition and negative symptoms among individuals with schizophrenia: A randomized controlled trial.
     Psychiatry Res. 2022;320:115033.
     

     >> Share

     
     
154. PENA-GARIJO J, Lacruz M, Masanet MJ, Palop-Grau A, et al
     Specific facial emotion recognition deficits across the course of psychosis: A comparison of individuals with low-risk, high-risk, first-episode psychosis and multi-episode schizophrenia-spectrum disorders.
     Psychiatry Res. 2022;320:115029.
     

     >> Share

     
     
155. STOROSUM BWC, Mattila T, Wohlfarth TD, Gispen-de Wied CC, et al
     Gender differences in the response to antipsychotic medication in patients with schizophrenia: An individual patient data meta-analysis of placebo-controlled studies.
     Psychiatry Res. 2022;320:114997.
     

     >> Share

     
     
156. ELLINI S, Romdhane IB, Bougacha D, Abassi A, et al
     COVID-19 induced psychosis: A case report.
     Psychiatry Res. 2022;320:115009.
     

     >> Share

     
     
157. GARRIDO-TORRES N, Alameda L, Rocha-Gonzalez I, Canal-Rivero M, et al
     Response to the letter to editor regarding "Higher rates of first episode psychosis in immigrants admitted in inpatient unit at southwest Spain".
     Psychiatry Res. 2022;322:115008.
     

     >> Share

     
     
158. MANNARINI S, Taccini F, Sato I, Rossi AA, et al
     Understanding stigma toward schizophrenia.
     Psychiatry Res. 2022;318:114970.
     

     >> Share

     
     
159. SOMMER IE, N de Boer J
     How to reap the benefits of language for psychiatry.
     Psychiatry Res. 2022;318:114932.
     

     >> Share

     
     November 2022
160. ROSEN RL, Ramasubramani RS, Benowitz NL, Gandhi KK, et al
     Caffeine levels and dietary intake in smokers with schizophrenia and bipolar disorder.
     Psychiatry Res. 2022;319:114989.
     

     >> Share

     
     
161. BASSETT AS
     Clinical genetics of schizophrenia and related neuropsychiatric disorders.
     Psychiatry Res. 2022;319:114992.
     

     >> Share

     
     
162. DUDLEY R, Watson F, O'Grady L, Aynsworth C, et al
     Prevalence and nature of multi-sensory and multi-modal hallucinations in people with first episode psychosis.
     Psychiatry Res. 2022;319:114988.
     

     >> Share

     
     
163. LAHTI AC
     Discovery of early schizophrenia through neuroimaging.
     Psychiatry Res. 2022;322:114993.
     

     >> Share

     
     
164. CELLA M, Sedgwick O, Lawrence M, Grant N, et al
     Evaluating the mechanisms of social cognition intervention in schizophrenia: A proof-of-concept trial.
     Psychiatry Res. 2022;319:114963.
     

     >> Share

     
     
165. TAO TJ, Hui CLM, Hui PWM, Ho ECN, et al
     Working memory deterioration as an early warning sign for relapse in remitted psychosis: A one-year naturalistic follow-up study.
     Psychiatry Res. 2022;319:114976.
     

     >> Share

     
     
166. XIE Y, Guan M, Cai Y, Wang Z, et al
     Impact of low-frequency repetitive transcranial magnetic stimulation on functional network connectivity in schizophrenia patients with auditory verbal hallucinations.
     Psychiatry Res. 2022;320:114974.
     

     >> Share

     
     
167. GOODING DC
     Social anhedonia and other indicators of risk for schizophrenia: Theory and inquiry.
     Psychiatry Res. 2022;319:114966.
     

     >> Share

     
     
168. CHA M, Al-Chalabi N, Qian J, Chaudhary Z, et al
     Concordance between the Columbia-Suicide Severity Rating Scale and Beck Scale for Suicide Ideation in assessing suicide behaviour in young adults with schizophrenia spectrum disorders.
     Psychiatry Res. 2022;319:114965.
     

     >> Share

     
     
169. LV H, Li J, Gao K, Zeng L, et al
     Identification of genetic loci that overlap between schizophrenia and metabolic syndrome.
     Psychiatry Res. 2022;318:114947.
     

     >> Share

     
     
170. RUIZ-DELGADO I, Moreno-Kustner B, Garcia-Medina M, Barrigon ML, et al
     Is Metacognitive Training effective for improving neurocognitive function in patients with a recent onset of psychosis?
     Psychiatry Res. 2022;318:114941.
     

     >> Share

     
     
171. SCHWAB SG
     Genetic variation and susceptibility to schizophrenia: Work in progress.
     Psychiatry Res. 2022;318:114949.
     

     >> Share

     
     
172. ZHANG Q, Huo JH, Guo L, Wang L, et al
     Common and rare variants within SP4 exert distinct molecular mechanisms contributing to the risk of schizophrenia.
     Psychiatry Res. 2022;318:114948.
     

     >> Share

     
     
173. LU W, Srijeyanthan J, Mueser KT, Yanos PT, et al
     Predictors of undocumented PTSD in persons using public mental health services.
     Psychiatry Res. 2022;317:114892.
     

     >> Share

     
     
174. KIM WS, Heo DW, Shen J, Tsogt U, et al
     Altered functional connectivity in psychotic disorder not otherwise specified.
     Psychiatry Res. 2022;317:114871.
     

     >> Share

     
     
175. LANGLOIS T, Sanchez-Rodriguez R, Bourcier A, Lamy P, et al
     "Accept voices(c)" group intervention for the management of auditory verbal hallucinations-results at 6 and 12 months.
     Psychiatry Res. 2022;317:114860.
     

     >> Share

     
     
176. RIHAL V, Khan H, Kaur A, Singh TG, et al
     Therapeutic and mechanistic intervention of vitamin D in neuropsychiatric disorders.
     Psychiatry Res. 2022;317:114782.
     

     >> Share

     
     October 2022
177. ZHANG T, Zeng J, Wei Y, Ye J, et al
     Changes in inflammatory balance correlates with conversion to psychosis among individuals at clinical high-risk: A prospective cohort study.
     Psychiatry Res. 2022;318:114938.
     

     >> Share

     
     
178. SCHELIGA S, Schwank R, Scholle R, Habel U, et al
     A neural mechanism underlying predictive visual motion processing in patients with schizophrenia.
     Psychiatry Res. 2022;318:114934.
     

     >> Share

     
     
179. CUESTA MJ, Sanchez-Torres AM, Moreno-Izco L, Garcia de Jalon E, et al
     Neurocognitive correlates of the varied domains of outcomes at 20 year follow-up of first-episode psychosis.
     Psychiatry Res. 2022;318:114933.
     

     >> Share

     
     
180. ENDRES D, Lerchenmuller V, Runge K, von Zedtwitz K, et al
     Anti-astrocytic autoantibody patterns in the cerebrospinal fluid of patients with depression and psychosis.
     Psychiatry Res. 2022;317:114905.
     

     >> Share

     
     
181. GIZDIC A, Baxter T, Barrantes-Vidal N, Park S, et al
     Loneliness and psychosocial predictors of psychosis-proneness during COVID-19: Preliminary findings from Croatia.
     Psychiatry Res. 2022;317:114900.
     

     >> Share

     
     
182. DEAN B, Thomas EHX, Bozaoglu K, Tan EJ, et al
     Evidence that a working memory cognitive phenotype within schizophrenia has a unique underlying biology.
     Psychiatry Res. 2022;317:114873.
     

     >> Share

     
     
183. PELIZZA L, Quattrone E, Leuci E, Paulillo G, et al
     Anxious-depressive symptoms after a first episode of schizophrenia: Response to treatment and psychopathological considerations from the 2-year "Parma Early Psychosis" program.
     Psychiatry Res. 2022;317:114887.
     

     >> Share

     
     
184. BARLATI S, Nibbio G, Bianchi F, Gigli EBL, et al
     Long-acting Injectable Antipsychotics during the COVID-19 pandemic in schizophrenia: An observational study in a real-world clinical setting.
     Psychiatry Res. 2022;317:114878.
     

     >> Share

     
     
185. DOKUZ G, Kani AS, Uysal O, Kuscu MK, et al
     The impact of childhood trauma and daily life experiences on emotional and psychotic symptom intensity in psychosis: An experience sampling study.
     Psychiatry Res. 2022;317:114872.
     

     >> Share

     
     September 2022
186. UPTHEGROVE R
     From co-morbidity to transdiagnostic potential and novel immunotherapies for psychosis.
     Psychiatry Res. 2022;317:114866.
     

     >> Share

     
     
187. MORITZ S, Goritz AS, Franz C, Sibilis A, et al
     Whodunit - A novel video-based task for the measurement of jumping to conclusions in the schizophrenia spectrum.
     Psychiatry Res. 2022;317:114862.
     

     >> Share

     
     
188. WALKER E
     The permeable boundary between biological and psychological processes in the origins of psychosis.
     Psychiatry Res. 2022;317:114853.
     

     >> Share

     
     
189. MALASPINA D
     A sisters search for the seeds of psychosis.
     Psychiatry Res. 2022;317:114846.
     

     >> Share

     
     
190. SNELLEKSZ M, Rossell SL, Gibbons A, Nithianantharajah J, et al
     Evidence that the frontal pole has a significant role in the pathophysiology of schizophrenia.
     Psychiatry Res. 2022;317:114850.
     

     >> Share

     
     
191. YAO L, Liu H, Tian X
     Medication adherence among community-dwelling schizophrenia patients during the COVID-19 pandemic: A cross-sectional study.
     Psychiatry Res. 2022;317:114841.
     

     >> Share

     
     August 2022
192. KOOPOWITZ SM, Cotton SM, Uhlmann A, Thomas KGF, et al
     Executive function in methamphetamine users with and without psychosis.
     Psychiatry Res. 2022;317:114820.
     

     >> Share

     
     
193. BIZUMIC B, Gunningham B, Christensen BK
     Prejudice towards people with mental illness, schizophrenia, and depression among mental health professionals and the general population.
     Psychiatry Res. 2022;317:114817.
     

     >> Share

     
     
194. EATON WW, Rodriguez KM, Thomas MA, Johnson J, et al
     Immunologic profiling in schizophrenia and rheumatoid arthritis.
     Psychiatry Res. 2022;317:114812.
     

     >> Share

     
     
195. BARANOVA A, Cao H, Zhang F
     Severe COVID-19 increases the risk of schizophrenia.
     Psychiatry Res. 2022;317:114809.
     

     >> Share

     
     
196. MCCARTHY JM, Wood AJ, Shinners MG, Heinrich H, et al
     Pilot development and feasibility of telehealth Community Reinforcement and Family Training (CRAFT) for early psychosis and substance use.
     Psychiatry Res. 2022;317:114804.
     

     >> Share

     
     
197. HU M, Xia Y, Zong X, Sweeney JA, et al
     Risperidone-induced changes in DNA methylation in peripheral blood from first-episode schizophrenia patients parallel changes in neuroimaging and cognitive phenotypes.
     Psychiatry Res. 2022;317:114789.
     

     >> Share

     
     
198. LYNCH DA, Brown M, Saperstein A, Stefancic A, et al
     Assessing metamotivation in schizophrenia: A pilot study of the Brief Regulation of Motivation Scale (BRoMS).
     Psychiatry Res. 2022;317:114799.
     

     >> Share

     
     
199. LI Z, Chen X
     Comprehensive analysis of shared genetic loci between hippocampal volume and schizophrenia.
     Psychiatry Res. 2022;316:114795.
     

     >> Share

     
     
200. TIKKANEN V, Siira V, Wahlberg KE, Hakko H, et al
     Deficits in adolescent social functioning, dysfunctional family processes and genetic risk for schizophrenia spectrum disorders as risk factors for later psychiatric morbidity of adoptees.
     Psychiatry Res. 2022;316:114793.
     

     >> Share

     
     
201. LIU CM, Liu CC, Hsieh MH, Hwang TJ, et al
     The plasma level of complement component 4A decreases with aripiprazole treatment in patients with early psychosis.
     Psychiatry Res. 2022;316:114775.
     

     >> Share

     
     
202. HERPERTZ J, Richter MF, Barkhau C, Storck M, et al
     Symptom monitoring based on digital data collection during inpatient treatment of schizophrenia spectrum disorders - A feasibility study.
     Psychiatry Res. 2022;316:114773.
     

     >> Share

     
     
203. CAI H, Zeng C, Zhang X, Liu Y, et al
     Diminished treatment response in relapsed versus first-episode schizophrenia as revealed by a panel of blood-based biomarkers: A combined cross-sectional and longitudinal study.
     Psychiatry Res. 2022;316:114762.
     

     >> Share

     
     
204. KOOL L, Oranje B, Meijs H, De Wilde B, et al
     Event-related potentials and use of psychotropic medication in major psychiatric disorders.
     Psychiatry Res. 2022;314:114637.
     

     >> Share

     
     
205. PUJOL N, Berge D, Mane A, Bioque M, et al
     The influence of modifiable cardiovascular risk factors on cognition, functioning, and inflammatory markers in first-episode psychosis: Results from a 2-year follow-up study.
     Psychiatry Res. 2022;316:114760.
     

     >> Share

     
     July 2022
206. SALEHI A, Namaei P, TaghaviZanjani F, Bagheri S, et al
     Adjuvant palmitoylethanolamide therapy with risperidone improves negative symptoms in patients with schizophrenia: A randomized, double-blinded, placebo-controlled trial.
     Psychiatry Res. 2022;316:114737.
     

     >> Share

     
     
207. DESAI SS, Nguyen AL, Bernstein GA
     Letter to editor: Case report of long COVID-19 with psychosis in a child.
     Psychiatry Res. 2022;316:114743.
     

     >> Share

     
     
208. SEEMAN MV
     Sex/Gender differences in schizophrenia: Thinking back and thinking forward.
     Psychiatry Res. 2022;316:114738.
     

     >> Share

     
     
209. DADERWAL MC, Sreeraj VS, Suhas S, Rao NP, et al
     Montreal Cognitive Assessment (MoCA) and Digit Symbol Substitution Test (DSST) as a screening tool for evaluation of cognitive deficits in schizophrenia.
     Psychiatry Res. 2022;316:114731.
     

     >> Share

     
     
210. GALLIOT G, Sanchez-Rodriguez R, Belloc A, Phulpin H, et al
     Is clinical insight a determinant factor of subjective recovery in persons living with schizophrenia or schizoaffective disorders?
     Psychiatry Res. 2022;316:114726.
     

     >> Share

     
     
211. PARK HJ, Kang WS, Oh M, Kim JW, et al
     Association of the promoter haplotype in CDK5 gene with schizophrenia in a Korean population.
     Psychiatry Res. 2022;316:114723.
     

     >> Share

     
     
212. RIBOLSI M, Albergo G, Fiori Nastro F, Pelle M, et al
     Autistic symptomatology in UHR patients: A preliminary report.
     Psychiatry Res. 2022;313:114634.
     

     >> Share

     
     
213. NGUYEN T, Frayne J, Watson S, Lebedevs T, et al
     Long-acting injectable antipsychotic treatment during pregnancy: Outcomes for women at a tertiary maternity hospital.
     Psychiatry Res. 2022;313:114614.
     

     >> Share

     
     June 2022
214. DIAGO M, Vila-Badia R, Serra-Arumi C, Butjosa A, et al
     Emotional abuse and perceived stress: The most relevant factors in suicide behavior in first-episode psychosis patients.
     Psychiatry Res. 2022;315:114699.
     

     >> Share

     
     
215. JEREMIAN R, Malinowski A, Chaudhary Z, Srivastava A, et al
     Epigenetic age dysregulation in individuals with bipolar disorder and schizophrenia.
     Psychiatry Res. 2022;315:114689.
     

     >> Share

     
     
216. RAMAIN J, Conus P, Golay P
     Grouping affective psychoses in early intervention: Justification for specific treatment guidelines.
     Psychiatry Res. 2022;314:114690.
     

     >> Share

     
     
217. ZARBO C, Agosta S, Casiraghi L, De Novellis A, et al
     Assessing adherence to and usability of Experience Sampling Method (ESM) and actigraph in patients with Schizophrenia Spectrum Disorder: A mixed-method study.
     Psychiatry Res. 2022;314:114675.
     

     >> Share

     
     May 2022
218. LI Z, Li X, Jin M, Liu Y, et al
     Identification of potential biomarkers and their correlation with immune infiltration cells in schizophrenia using combinative bioinformatics strategy.
     Psychiatry Res. 2022;314:114658.
     

     >> Share

     
     
219. SHIMADA T, Ito S, Makabe A, Yamanushi A, et al
     Aerobic exercise and cognitive functioning in schizophrenia: An updated systematic review and meta-analysis.
     Psychiatry Res. 2022;314:114656.
     

     >> Share

     
     
220. KIRSCHENBAUM MA, Lopez LV, de Filippis R, Ali AF, et al
     Validation of a novel Psychosis-Implicit Association Test (P-IAT) as a diagnostic support tool.
     Psychiatry Res. 2022;314:114647.
     

     >> Share

     
     
221. BHATTACHARYYA U, Bhatia T, Deshpande SN, Thelma BK, et al
     Genetic variations in evolutionary accelerated regions disrupt cognition in schizophrenia.
     Psychiatry Res. 2022;314:114586.
     

     >> Share

     
     
222. XU L, Hao D, Wei Y, Cui H, et al
     Effect of cognitive insight on clinical insight from pre-morbid to early psychosis stages.
     Psychiatry Res. 2022;313:114613.
     

     >> Share

     
     
223. CAO X, Chen S, Xu H, Wang Q, et al
     Global functioning, cognitive function, psychopathological symptoms in untreated patients with first-episode schizophrenia: A cross-sectional study.
     Psychiatry Res. 2022;313:114616.
     

     >> Share

     
     
224. LONG J, Tian L, Baranova A, Cao H, et al
     Convergent lines of evidence supporting involvement of NFKB1 in schizophrenia.
     Psychiatry Res. 2022;312:114588.
     

     >> Share

     
     
225. KATZ IR, Szymanski BR, Marder SR, Shotwell A, et al
     Comparative risks of all-cause mortality for Veterans with schizophrenia with ongoing receipt of clozapine and other antipsychotic medications.
     Psychiatry Res. 2022;313:114590.
     

     >> Share

     
     April 2022
226. THAI H, Robertson C, Friberg L, Hatko A, et al
     WHODAS 2.0: Associations of functional disability with sex, age, and length of care in outpatients with schizophrenia-spectrum disorders.
     Psychiatry Res. 2022;313:114583.
     

     >> Share

     
     
227. MARTINS PS, Caldas F, Oliveira C, Mota J, et al
     A 10-year mirror-image study of effectiveness and cost of long-acting paliperidone palmitate injectable in patients with schizophrenia or schizoaffective disorder.
     Psychiatry Res. 2022;312:114581.
     

     >> Share

     
     
228. LI X, Yuan X, Pang L, Zhang S, et al
     nThe effect of serum lipids and short-chain fatty acids on cognitive functioning in drug-naive, first episode schizophrenia patients.
     Psychiatry Res. 2022;313:114582.
     

     >> Share

     
     
229. XU Y, Cai Z, Fang C, Zheng J, et al
     Impact of aerobic exercise on cognitive function in patients with schizophrenia during daily care: A meta-analysis.
     Psychiatry Res. 2022;312:114560.
     

     >> Share

     
     
230. OUYANG H, Huang M, Chen S, Wu X, et al
     Peripheral lower triiodothyronine levels related to interleukin-6 in patients with first-episode schizophrenia.
     Psychiatry Res. 2022;312:114546.
     

     >> Share

     
     
231. WELCH KG, Stiles BJ, Palsson OS, Meyer-Kalos PS, et al
     The use of diary methods to evaluate daily experiences in first-episode psychosis.
     Psychiatry Res. 2022;312:114548.
     

     >> Share

     
     
232. GONZALEZ-RODRIGUEZ A, Monreal JA, Porras-Segovia A, Cervilla JA, et al
     Psychometric instruments for the assessment of depressive symptoms in patients with delusional disorder: A systematic review.
     Psychiatry Res. 2022;310:114435.
     

     >> Share

     
     March 2022
233. JAISWAL N, Kar SK, Gupta PK
     Comments on "High frequency repetitive transcranial magnetic stimulation of dorsomedial prefrontal cortex for negative symptoms in patients with schizophrenia: A double-blind, randomized controlled trial".
     Psychiatry Res. 2022;312:114532.
     

     >> Share

     
     
234. PANDOLFO G, Genovese G, Bruno A, Campolo D, et al
     Advanced glycation end-products and advanced oxidation protein products in schizophrenia.
     Psychiatry Res. 2022;311:114527.
     

     >> Share

     
     
235. LI J, Zhang X, Jiang J, Zhang B, et al
     Comparison of electroconvulsive therapy and magnetic seizure therapy in schizophrenia: Structural changes/neuroplasticity.
     Psychiatry Res. 2022;312:114523.
     

     >> Share

     
     
236. BORNHEIMER LA, Li Verdugo J, Holzworth J, Im V, et al
     Modifying a cognitive behavioral suicide prevention treatment for adults with schizophrenia spectrum disorders in community mental health.
     Psychiatry Res. 2022;311:114505.
     

     >> Share

     
     
237. XU X, Shao G, Zhang X, Hu Y, et al
     The efficacy of nutritional supplements for the adjunctive treatment of schizophrenia in adults: A systematic review and network meta-analysis.
     Psychiatry Res. 2022;311:114500.
     

     >> Share

     
     
238. RAMMOUZ I, Bouri S, Merzouki M, Berraho MA, et al
     Reliability of self-report of cannabis use among patients with schizophrenia.
     Psychiatry Res. 2022;311:114491.
     

     >> Share

     
     
239. KEMPPAINEN A, Lindgren M, Suvisaari J, Kieseppa T, et al
     Adverse childhood experiences and social and occupational functioning in first-episode psychosis - A one year follow - up.
     Psychiatry Res. 2022;311:114502.
     

     >> Share

     
     
240. MUNIR K, Oner O, Kerala C, Rustamov I, et al
     Social distance and stigma towards persons with serious mental illness among medical students in five European Central Asia countries.
     Psychiatry Res. 2022;309:114409.
     

     >> Share

     
     February 2022
241. GOHARI E, Moore RC, Depp CA, Ackerman RA, et al
     Momentary severity of psychotic symptoms predicts overestimation of competence in domains of everyday activities and work in schizophrenia: An ecological momentary assessment study.
     Psychiatry Res. 2022;310:114487.
     

     >> Share

     
     
242. LIU Y, Jia LN, Wu H, Jiang W, et al
     Adjuvant electroconvulsive therapy with antipsychotics is associated with improvement in auditory mismatch negativity in schizophrenia.
     Psychiatry Res. 2022;311:114484.
     

     >> Share

     
     
243. COWAN T, Cohen AS, Raugh IM, Strauss GP, et al
     Ambulatory audio and video recording for digital phenotyping in schizophrenia: Adherence & data usability.
     Psychiatry Res. 2022;311:114485.
     

     >> Share

     
     
244. SANTESTEBAN-ECHARRI O, Sandel D, Liu L, Bearden CE, et al
     Family history of psychosis in youth at clinical high risk: A replication study.
     Psychiatry Res. 2022;311:114480.
     

     >> Share

     
     
245. MORIKAWA R, Watanabe Y, Igeta H, Arta RK, et al
     Novel missense SETD1A variants in Japanese patients with schizophrenia: Resequencing and association analysis.
     Psychiatry Res. 2022;310:114481.
     

     >> Share

     
     
246. RODRIGUEZ M, Knizkova K, Kerkova B, Sironova A, et al
     The relationships between cognitive reserve, cognitive functioning and quality of life in first-episode schizophrenia spectrum disorders.
     Psychiatry Res. 2022;310:114479.
     

     >> Share

     
     
247. LEE HS, Rast C, Shenoy S, Dean D, et al
     A meta-analytic review of transcranial direct current stimulation (tDCS) on general psychopathology symptoms of schizophrenia; immediate improvement followed by a return to baseline.
     Psychiatry Res. 2022;310:114471.
     

     >> Share

     
     
248. SONG W, Lin GN, Yu S, Zhao M, et al
     Genome-wide identification of the shared genetic basis of cannabis and cigarette smoking and schizophrenia implicates NCAM1 and neuronal abnormality.
     Psychiatry Res. 2022;310:114453.
     

     >> Share

     
     
249. TAN EJ, Toh WL, Rossell SL
     Examining relationships between state and trait psychotic symptoms and quality of life in schizophrenia spectrum disorders.
     Psychiatry Res. 2022;310:114450.
     

     >> Share

     
     
250. LOPEZ-NAVARRO E, Fonseca-Pedrero E, Errasti J, Al-Halabi S, et al
     Mindfulness improves theory of mind in people experiencing psychosis: A pilot randomized clinical trial.
     Psychiatry Res. 2022;310:114440.
     

     >> Share

     
     
251. GOH XX, Tang PY, Tee SF
     Effects of antipsychotics on antioxidant defence system in patients with schizophrenia: A meta-analysis.
     Psychiatry Res. 2022;309:114429.
     

     >> Share

     
     
252. SCHWARTZ EK, Le TP, Cohen AS
     Sharing positive events: Ecological momentary assessment of emotion regulation via social capitalization in schizotypy.
     Psychiatry Res. 2022;308:114377.
     

     >> Share

     
     
253. GROENMAN AP, van der Werf S, Geurts HM
     Subjective cognition in adults with common psychiatric classifications; a systematic review.
     Psychiatry Res. 2022;308:114374.
     

     >> Share

     
     January 2022
254. JEONG JH, Kim SW, Lee BJ, Kim JJ, et al
     The factor structure and clinical utility of clinician-rated dimensions of psychosis symptom severity in patients with recent-onset psychosis: Results of a 1-year longitudinal follow-up prospective cohort study.
     Psychiatry Res. 2022;310:114420.
     

     >> Share

     
     
255. BARTOLI F, Cavaleri D, Callovini T, Riboldi I, et al
     Comparing 1-year effectiveness and acceptability of once-monthly paliperidone palmitate and aripiprazole monohydrate for schizophrenia spectrum disorders: Findings from the STAR Network Depot Study.
     Psychiatry Res. 2022;309:114405.
     

     >> Share

     
     
256. LUNDIN NB, Jones MN, Myers EJ, Breier A, et al
     Semantic and phonetic similarity of verbal fluency responses in early-stage psychosis.
     Psychiatry Res. 2022;309:114404.
     

     >> Share

     
     
257. XIE Y, He Y, Guan M, Wang Z, et al
     Low-frequency rTMS treatment alters the topographical organization of functional brain networks in schizophrenia patients with auditory verbal hallucination.
     Psychiatry Res. 2022;309:114393.
     

     >> Share

     
     
258. RAULT O, Lamothe H, Pelissolo A
     Therapeutic use of virtual reality relaxation in schizophrenia: A pilot study.
     Psychiatry Res. 2022;309:114389.
     

     >> Share

     
     
259. VERDOUX H, Sibert A, Quiles C
     Trauma and resistance to antipsychotic treatment in schizophrenia: A narrative review.
     Psychiatry Res. 2022;309:114392.
     

     >> Share

     
     
260. MORAN LV, Tsang ES, Ongur D, Hsu J, et al
     Geographical variation in hospitalization for psychosis associated with cannabis use and cannabis legalization in the United States: Submit to: Psychiatry Research.
     Psychiatry Res. 2022;308:114387.
     

     >> Share

     
     
261. SINGH A, Kumar V, Pathak H, Jacob AA, et al
     Effect of antipsychotic dose reduction on cognitive function in schizophrenia.
     Psychiatry Res. 2022;308:114383.
     

     >> Share

     
     
262. GANDHI A, Mote J, Fulford D
     A transdiagnostic meta-analysis of physical and social Anhedonia in major depressive disorder and schizophrenia spectrum disorders.
     Psychiatry Res. 2022;309:114379.
     

     >> Share

     
     December 2021
263. LABONTE C, Zhand N, Park A, Harvey PD, et al
     Complete blood count inflammatory markers in treatment-resistant schizophrenia: Evidence of association between treatment responsiveness and levels of inflammation.
     Psychiatry Res. 2021;308:114382.
     

     >> Share

     
     
264. GICAS KM, Parmar PK, Fabiano GF, Mashhadi F, et al
     Substance-induced psychosis and cognitive functioning: A systematic review.
     Psychiatry Res. 2021;308:114361.
     

     >> Share

     
     
265. GARRIDO-TORRES N, Suarez-Suarez ML, Rocha-Gonzalez I, Alameda L, et al
     Higher rates of first episode psychosis in immigrants admitted in inpatient unit at southwest Spain.
     Psychiatry Res. 2021;308:114352.
     

     >> Share

     
     
266. VERU F, MacDonald K, Malla A, Pruessner M, et al
     The effects of childhood adversity on treatment delays and its components in first-episode psychosis.
     Psychiatry Res. 2021;308:114341.
     

     >> Share

     
     
267. LAVAUD P, McMahon K, Sanchez Rico M, Hanon C, et al
     Long-term care utilization within older adults with schizophrenia: Associated factors in a multicenter study.
     Psychiatry Res. 2021;308:114339.
     

     >> Share

     
     
268. LIU X, Wang D, Fan R, Wang R, et al
     Life expectancy and potential years of life lost for schizophrenia in western China.
     Psychiatry Res. 2021;308:114330.
     

     >> Share

     
     
269. LOCKWOOD L, Miller B, Youssef NA
     Epigenetics and first-episode psychosis: A systematic review.
     Psychiatry Res. 2021;307:114325.
     

     >> Share

     
     
270. THOMPSON EC, Visser KF, Schiffman J, Spirito A, et al
     Preliminary evidence supporting the practice of psychosis-risk screening within an inpatient psychiatric setting serving adolescents.
     Psychiatry Res. 2021;307:114322.
     

     >> Share

     
     
271. LEE S, Schwartz S
     Adherence and persistence to long-acting injectable dopamine receptor blocking agent therapy in the United States: A systematic review and meta-analysis of cohort studies.
     Psychiatry Res. 2021;306:114277.
     

     >> Share

     
     November 2021
272. LOCH AA, Mota NB, Rossler W, Gattaz WF, et al
     Exacerbation of psychosis risk during the COVID-19 pandemic: The disproportionate impact on the lower income population.
     Psychiatry Res. 2021;307:114319.
     

     >> Share

     
     
273. ALLIENDE LM, Czepielewski LS, Aceituno D, Castaneda CP, et al
     Gender, age and geographical representation over the past 50 years of schizophrenia research.
     Psychiatry Res. 2021;307:114279.
     

     >> Share

     
     
274. FERNANDEZ DK, Deane FP, Vella SA
     Effects of online continuum and categorical belief manipulations on schizophrenia stigma, help-seeking, and help-provision.
     Psychiatry Res. 2021;307:114293.
     

     >> Share

     
     
275. CHEN S, Tang Y, Fan X, Qiao Y, et al
     The role of white matter abnormality in the left anterior corona radiata: In relation to formal thought disorder in patients with schizophrenia.
     Psychiatry Res. 2021;307:114302.
     

     >> Share

     
     
276. GOU N, Xiang Y, Zhou J, Zhang S, et al
     Identification of violent patients with schizophrenia using a hybrid machine learning approach at the individual level.
     Psychiatry Res. 2021;306:114294.
     

     >> Share

     
     
277. LAI M, Hegde R, Kelly S, Bannai D, et al
     Investigating sleep spindle density and schizophrenia: A meta-analysis.
     Psychiatry Res. 2021;307:114265.
     

     >> Share

     
     
278. BARR SM, Roberts D, Thakkar KN
     Psychosis in transgender and gender non-conforming individuals: A review of the literature and a call for more research.
     Psychiatry Res. 2021;306:114272.
     

     >> Share

     
     
279. LYU J, Zhang J
     Suicide means, timing, intent and behavior characteristics of the suicides with schizophrenia.
     Psychiatry Res. 2021;306:114267.
     

     >> Share

     
     
280. RUSSO M, Consoli S, De Rosa MA, Calisi D, et al
     A case of Sars-Cov-2-related mania with prominent psychosis>.
     Psychiatry Res. 2021;306:114266.
     

     >> Share

     
     
281. GALLOS IK, Mantonakis L, Spilioti E, Kattoulas E, et al
     The relation of integrated psychological therapy to resting state functional brain connectivity networks in patients with schizophrenia.
     Psychiatry Res. 2021;306:114270.
     

     >> Share

     
     
282. SANTOS MJ, Ferreira TF, Sequeira M, Trancas B, et al
     Chronic hallucinatory psychosis presenting with olfactory hallucinations: A case report.
     Psychiatry Res. 2021;305:114262.
     

     >> Share

     
     
283. SAHYOUNI C, Hefazi E
     Clozapine induced pericarditis: A case report.
     Psychiatry Res. 2021;305:114250.
     

     >> Share

     
     
284. SHROITMAN NK, Peles E, Even-Tov S, Schreiber S, et al
     False-positive fentanyl screening kit results during treatment with long term injectable risperidone (Risperdal-Consta).
     Psychiatry Res. 2021;305:114246.
     

     >> Share

     
     
285. RICHARDSON N, Greenway SC, Bousman CA
     Clozapine-induced myocarditis and patient outcomes after drug rechallenge following myocarditis: A systematic case review.
     Psychiatry Res. 2021;305:114247.
     

     >> Share

     
     
286. BRASSO C, Cisotto M, Ghirardini C, Pennazio F, et al
     Accuracy of self-reported adherence and therapeutic drug monitoring in a psychiatric emergency ward.
     Psychiatry Res. 2021;305:114214.
     

     >> Share

     
     
287. GROT S, Giguere CE, Smine S, Mongeau-Perusse V, et al
     Converting scores between the PANSS and SAPS/SANS beyond the positive/negative dichotomy.
     Psychiatry Res. 2021;305:114199.
     

     >> Share

     
     
288. MILLER BJ, McCall WV, McEvoy JP, Lu XY, et al
     Insomnia and inflammation in phase 1 of the clinical antipsychotic trials of intervention effectiveness study.
     Psychiatry Res. 2021;305:114195.
     

     >> Share

     
     October 2021
289. MENON V, Suhas S, Sethi MIS, Varadharajan N, et al
     Comments on the paper published by Lyu et al on Risk Factors for Suicide in People with Schizophrenia.
     Psychiatry Res. 2021;306:114255.
     

     >> Share

     
     
290. DAMIANO RF, Avrichir BS, Melzer-Ribeiro DL, Sallet PC, et al
     Which are the best evidence-based therapeutic options for clozapine and ECT resistant schizophrenia? A case-report.
     Psychiatry Res. 2021;305:114248.
     

     >> Share

     
     
291. PAWELCZYK A, Lojek E, Radek M, Pawelczyk T, et al
     Prosodic deficits and interpersonal difficulties in patients with schizophrenia.
     Psychiatry Res. 2021;306:114244.
     

     >> Share

     
     
292. LUO X, Zhang L, Zhang J, Chen H, et al
     Changes in the cognitive function of Chinese college students with a clinical high risk of psychosis.
     Psychiatry Res. 2021;305:114242.
     

     >> Share

     
     
293. CLAYSON PE, Molina JL, Joshi YB, Thomas ML, et al
     Evaluation of the frequency following response as a predictive biomarker of response to cognitive training in schizophrenia.
     Psychiatry Res. 2021;305:114239.
     

     >> Share

     
     
294. JIANG W, Rootes-Murdy K, Chen J, Bizzozero NIP, et al
     Multivariate alterations in insula - Medial prefrontal cortex linked to genetics in 12q24 in schizophrenia.
     Psychiatry Res. 2021;306:114237.
     

     >> Share

     
     
295. SANCHEZ MC, Escurriola MF, Sanmartin MIF, Solntseva I, et al
     Cardiovascular disease and mortality in people with schizophrenia or antipsychotic treatment: A cohort study in primary care.
     Psychiatry Res. 2021;306:114233.
     

     >> Share

     
     
296. BRYCE S, Zbukvic I, Wood SJ, Allott K, et al
     Cognitive remediation to address impairment in schizophrenia: Moving beyond effectiveness and toward implementation.
     Psychiatry Res. 2021;305:114232.
     

     >> Share

     
     
297. MINICHINO A, Singh F, Pineda J, Friederich E, et al
     Corrigendum to 'Biological Motion induced mu suppression is reduced in Early Psychosis (EP) patients with active negative symptoms and Autism Spectrum Disorders (ASD)' [Psychiatry Research 238 (2016) 374-377].
     Psychiatry Res. 2021;306:114177.
     

     >> Share

     
     
298. SARZYNSKA-WAWER J, Wawer A, Pawlak A, Szymanowska J, et al
     Detecting formal thought disorder by deep contextualized word representations.
     Psychiatry Res. 2021;304:114135.
     

     >> Share

     
     September 2021
299. LUDTKE T, Ruegg N, Moritz S, Berger T, et al
     Insight and the number of completed modules predict a reduction of positive symptoms in an Internet-based intervention for people with psychosis.
     Psychiatry Res. 2021;306:114223.
     

     >> Share

     
     
300. ZOU DS, Cowan HR, Azis M, Mittal VA, et al
     Reciprocal Social Behavior and Related Social Outcomes in Individuals at Clinical High Risk for Psychosis.
     Psychiatry Res. 2021;306:114224.
     

     >> Share

     
     
301. SRIVASTAVA A, Dada O, Qian J, Al-Chalabi N, et al
     Epigenetics of Schizophrenia.
     Psychiatry Res. 2021;305:114218.
     

     >> Share

     
     
302. FERNANDO R, Gan L, Xiao J, Yun Y, et al
     Hyperprolactinemia induced by brexpiprazole in patients with schizophrenia: A case report.
     Psychiatry Res. 2021;305:114215.
     

     >> Share

     
     
303. HOMMAN LE, Smart SE, O'Neill F, MacCabe JH, et al
     Attrition in longitudinal studies among patients with schizophrenia and other psychoses; findings from the STRATA collaboration.
     Psychiatry Res. 2021;305:114211.
     

     >> Share

     
     
304. MISHRA A, Soni AB, Umate MS, Andrade C, et al
     An exploratory evaluation of predictors of duration of untreated psychosis in first-episode psychosis in lower income patients.
     Psychiatry Res. 2021;305:114203.
     

     >> Share

     
     
305. ZHU L, Zhang W, Zhu Y, Mu X, et al
     Cerebellar theta burst stimulation for the treatment of negative symptoms of schizophrenia: A multicenter, double-blind, randomized controlled trial.
     Psychiatry Res. 2021;305:114204.
     

     >> Share

     
     
306. SHOSHINA II, Hovis JK, Felisberti FM, Santos NA, et al
     Visual processing and BDNF levels in first-episode schizophrenia.
     Psychiatry Res. 2021;305:114200.
     

     >> Share

     
     
307. RABINOWITZ J, Rabinowitz AA
     Outlier-response pattern checks to improve measurement with the Positive and Negative Syndrome Scale (PANSS).
     Psychiatry Res. 2021;303:114114.
     

     >> Share

     
     
308. VALERIO KE, Jonas KG, Perlman G, Bromet EJ, et al
     A comparison of cognitive performance in the Suffolk County cohort and their unaffected siblings.
     Psychiatry Res. 2021;303:114111.
     

     >> Share

     
     August 2021
309. KARTALCI S, Erbay MF, Kahraman A, Candir F, et al
     Evaluation of CSF flow dynamics in patients with schizophrenia using phase-contrast cine MRI.
     Psychiatry Res. 2021;304:114172.
     

     >> Share

     
     
310. REINFELD S, Caceda R, Gil R, Strom H, et al
     Can new onset psychosis occur after mRNA based COVID-19 vaccine administration? A case report.
     Psychiatry Res. 2021;304:114165.
     

     >> Share

     
     
311. LYU J, Zhang J, Hennessy DA
     Characteristics and Risk Factors for Suicide in People with Schizophrenia in Comparison to Those without Schizophrenia.
     Psychiatry Res. 2021;304:114166.
     

     >> Share

     
     
312. YANG H, Xiao W, Yang M, Wang Y, et al
     Decreased neuregulin1beta1 in first episode and drug-naive patients with schizophrenia: Negative correlation with cognitive impairment.
     Psychiatry Res. 2021;304:114164.
     

     >> Share

     
     
313. SAHIN D, Hever F, Bossert M, Herwig K, et al
     Early and middle latency auditory event-related potentials do not explain differences in neuropsychological performance between schizophrenia spectrum patients and matched healthy controls.
     Psychiatry Res. 2021;304:114162.
     

     >> Share

     
     
314. DAURE C, Fortias M, Icick R, Delage C, et al
     Oral long acting antipsychotic penfluridol as a harm reduction treatment in a patient suffering from untreated schizophrenia and multiple drug dependence: A case report.
     Psychiatry Res. 2021;304:114147.
     

     >> Share

     
     
315. DEYO C, Langdon R
     Cognitive correlates of 'Formal Thought Disorder' in a non-clinical sample with elevated schizotypal traits.
     Psychiatry Res. 2021;302:113971.
     

     >> Share

     
     
316. BURNESS C, Corbet C, Beyene K, Webby C, et al
     Factors predicting high-dose and combined antipsychotic prescribing in New Zealand: High-dose antipsychotic prescribing.
     Psychiatry Res. 2021;302:113996.
     

     >> Share

     
     July 2021
317. DA MOTTA C, Pato MT, Barreto Carvalho C, Castilho P, et al
     The neurocognitive and functional profile of schizophrenia in a genetically homogenous European sample.
     Psychiatry Res. 2021;304:114140.
     

     >> Share

     
     
318. VOPPEL AE, de Boer JN, Brederoo SG, Schnack HG, et al
     Quantified language connectedness in schizophrenia-spectrum disorders.
     Psychiatry Res. 2021;304:114130.
     

     >> Share

     
     
319. BOSNJAK KUHARIC D, Makaric P, Kekin I, Rossini Gajsak L, et al
     Changes of neurocognitive status in patients with the first-episode psychosis after 18 months of treatment-A prospective cohort study.
     Psychiatry Res. 2021;304:114131.
     

     >> Share

     
     
320. GRACIA DFK, Gomes EMP, Coelho TA, Carriello M, et al
     Ficolin activation as a potential biomarker of the severity of schizophrenia.
     Psychiatry Res. 2021;304:114122.
     

     >> Share

     
     
321. KU BS, Pauselli L, Covington MA, Compton MT, et al
     Computational linguistic analysis applied to a semantic fluency task: A replication among first-episode psychosis patients with and without derailment and tangentiality.
     Psychiatry Res. 2021;304:114105.
     

     >> Share

     
     
322. SNELLEKSZ M, Dean B
     Lower levels of tubulin alpha 1b in the frontal pole in schizophrenia supports a role for changed cytoskeletal dynamics in the aetiology of the disorder.
     Psychiatry Res. 2021;303:114096.
     

     >> Share

     
     
323. VASKINN A, Engelstad KN, Torgalsboen AK, Rund BR, et al
     Childhood trauma, social cognition and schizophrenia: Specific association between physical neglect and cognitive theory of mind in homicide offenders.
     Psychiatry Res. 2021;303:114093.
     

     >> Share

     
     
324. JAGADHEESAN K, Danivas V, Itrat Q, Shekaran L, et al
     A 6-month study on the pattern of emergency department presentations for schizophrenia and other psychotic disorders during COVID-19 lockdown.
     Psychiatry Res. 2021;303:114081.
     

     >> Share

     
     June 2021
325. CORBERA S, Wexler BE, Bell MD, Pearlson G, et al
     Predictors of social functioning and quality of life in schizophrenia and autism spectrum disorder.
     Psychiatry Res. 2021;303:114087.
     

     >> Share

     
     
326. LI S, DeLisi LE, McDonough SI
     Rare germline variants in individuals diagnosed with schizophrenia within multiplex families.
     Psychiatry Res. 2021;303:114038.
     

     >> Share

     
     
327. CASADO-ORTEGA A, Vila-Badia R, Butjosa A, Del Cacho N, et al
     Social cognition and its relationship with sociodemographic, clinical, and psychosocial variables in first-episode psychosis.
     Psychiatry Res. 2021;302:114040.
     

     >> Share

     
     
328. ANDREOU D, Jorgensen KN, Wortinger LA, Engen K, et al
     Cytomegalovirus infection and IQ in patients with severe mental illness and healthy individuals.
     Psychiatry Res. 2021;300:113929.
     

     >> Share

     
     
329. BRAUN D, Schlossmann J, Haen E
     Asymmetric dimethylarginine in psychiatric disorders.
     Psychiatry Res. 2021;300:113901.
     

     >> Share

     
     May 2021
330. KELLY DL, Claxton A, Bidollari I, Du Y, et al
     Analysis of prolactin and sexual side effects in patients with schizophrenia who switched from paliperidone palmitate to aripiprazole lauroxil.
     Psychiatry Res. 2021;302:114030.
     

     >> Share

     
     
331. GUILLAUME F, Thomas E
     Recollection and familiarity in schizophrenia:An ERP investigation using face recognition exclusion tasks.
     Psychiatry Res. 2021;302:113973.
     

     >> Share

     
     
332. SCHEFFLER F, Phahladira L, Luckhoff H, du Plessis S, et al
     Cannabis use and clinical outcome in people with first-episode schizophrenia spectrum disorders over 24 months of treatment.
     Psychiatry Res. 2021;302:114022.
     

     >> Share

     
     
333. MUNOZ-SAMONS D, Tor J, Rodriguez-Pascual M, Alvarez-Subiela X, et al
     Recent stressful life events and stress sensitivity in children and adolescents at clinical risk for psychosis.
     Psychiatry Res. 2021;303:114017.
     

     >> Share

     
     
334. HELLER C, Weiss T, Del Re EC, Swago S, et al
     Smaller subcortical volumes and enlarged lateral ventricles are associated with higher global functioning in young adults with 22q11.2 deletion syndrome with prodromal symptoms of schizophrenia.
     Psychiatry Res. 2021;301:113979.
     

     >> Share

     
     
335. ABEL DB, Salyers MP, Wu W, Monette MA, et al
     Quality versus quantity: Determining real-world social functioning deficits in schizophrenia.
     Psychiatry Res. 2021;301:113980.
     

     >> Share

     
     April 2021
336. ALBA L, Coll C, Saez S, Alonso L, et al
     New-onset psychosis: A case report of brief psychosis related to COVID-19 infection.
     Psychiatry Res. 2021;301:113975.
     

     >> Share

     
     
337. UCOK A, Karakas B, Sahin OS
     Formal thought disorder in patients with first-episode schizophrenia: Results of a one-year follow-up study.
     Psychiatry Res. 2021;301:113972.
     

     >> Share

     
     
338. 
     Discrepancies between staff and gold standard ratings of schizophrenia symptom severity.
     Psychiatry Res. 2021;301:113963.
     

     >> Share

     
     
339. DE PERI L, Deste G, Vita A
     Strucutural brain imaging at the onset of schizophrenia:What have we learned and what have we missed.
     Psychiatry Res. 2021;301:113962.
     

     >> Share

     
     
340. MEDALIA A, Saperstein AM, Stefancic A, Meyler S, et al
     Feasibility and acceptability of remotely accessed cognitive remediation for schizophrenia in public health settings.
     Psychiatry Res. 2021;301:113956.
     

     >> Share

     
     
341. XIE YJ, Xi YB, Cui LB, Guan MZ, et al
     Functional connectivity of cerebellar dentate nucleus and cognitive impairments in patients with drug-naive and first-episode schizophrenia.
     Psychiatry Res. 2021;300:113937.
     

     >> Share

     
     
342. PENNOU A, Lecomte T, Khazaal Y, Potvin S, et al
     Does theory of mind predict specific domains of social functioning in individuals following a first episode psychosis?
     Psychiatry Res. 2021;301:113933.
     

     >> Share

     
     
343. WANG YY, Hsu SH, Tsai HY, Cheng MC, et al
     Sequencing of the coding regions of GNBIL on chromosome 22q11.2 as a risk gene of schizophrenia.
     Psychiatry Res. 2021;300:113943.
     

     >> Share

     
     
344. SCHURHOFF F, Corfdir C, Pignon B, Lajnef M, et al
     No alteration of leukocyte telomere length in first episode psychosis.
     Psychiatry Res. 2021;301:113941.
     

     >> Share

     
     
345. VAERNES TG, Rossberg JI, Melle I, Nelson B, et al
     Basic self-disturbance in subjects at clinical high risk for psychosis: Relationship with clinical and functional outcomes at one year follow-up.
     Psychiatry Res. 2021;300:113942.
     

     >> Share

     
     
346. STRASSNIG MT, Miller ML, Moore R, Depp CA, et al
     Evidence for avolition in bipolar disorder? A 30-day ecological momentary assessment comparison of daily activities in bipolar disorder and schizophrenia.
     Psychiatry Res. 2021;300:113924.
     

     >> Share

     
     
347. SIDDIQUI SV, Nizamie SH, Siddiqui MA, Jahan M, et al
     Evaluation of N-400 Evoked Response Potential in schizophrenia: An endophenotype or a disease marker?
     Psychiatry Res. 2021;300:113907.
     

     >> Share

     
     March 2021
348. AU RWC, Sezto HNW, Lam VWM, Wan YT, et al
     Brief report: A randomized controlled trial of a compensatory cognitive training to improve prospective memory performance in people with schizophrenia or depression.
     Psychiatry Res. 2021;300:113914.
     

     >> Share

     
     
349. LI M, Liu Y, Qiu Y, Zhang J, et al
     The effect of berberine adjunctive treatment on glycolipid metabolism in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial.
     Psychiatry Res. 2021;300:113899.
     

     >> Share

     
     
350. SIMON AE, Keller P, Cattapan K
     Commentary about social avoidance and its significance in adolescents and young adults.
     Psychiatry Res. 2021;297:113718.
     

     >> Share

     
     
351. TOYODA K, Hata T, Yamauchi S, Kinoshita S, et al
     A descriptive study of 10-year clozapine use from the nationwide database in Japan.
     Psychiatry Res. 2021;297:113764.
     

     >> Share

     
     
352. O'CONNOR C, Vaughan S
     Does selectively endorsing different approaches to treating mental illness affect lay beliefs about the cause and course of mental illness?
     Psychiatry Res. 2021;297:113726.
     

     >> Share

     
     February 2021
353. SREERAJ VS, Holla B, Ithal D, Nadella RK, et al
     Psychiatric symptoms and syndromes transcending diagnostic boundaries in Indian multiplex families: The cohort of ADBS study.
     Psychiatry Res. 2021;296:113647.
     

     >> Share

     
     
354. MORRIS E, Batallones R, Ryan J, Slomp C, et al
     Psychiatric genetic counseling for serious mental illness: Impact on psychopathology and psychotropic medication adherence.
     Psychiatry Res. 2021;296:113663.
     

     >> Share

     
     
355. CAMUS D, Dan Glauser ES, Gholamrezaee M, Gasser J, et al
     Factors associated with repetitive violent behavior of psychiatric inpatients.
     Psychiatry Res. 2021;296:113643.
     

     >> Share

     
     
356. GURCAN G, Senol SH, Yagcioglu AEA, Ertugrul A, et al
     Clinical risk factors, phenomenology and the impact of clozapine induced obsessive compulsive symptoms.
     Psychiatry Res. 2021;296:113665.
     

     >> Share

     
     
357. KHARE C, Mueser KT, Bahaley M, Vax S, et al
     Employment in people with severe mental illnesses receiving public sector psychiatric services in India.
     Psychiatry Res. 2021;296:113673.
     

     >> Share

     
     January 2021
358. KETHARANATHAN T, Pereira A, Reets U, Walker D, et al
     Brain changes in NF-kappaB1 and epidermal growth factor system markers at peri-pubescence in the spiny mouse following maternal immune activation.
     Psychiatry Res. 2021;295:113564.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share